Skip to content

Effect of Guduchighan Vati in Vatarakta ( Hyperuricemia)

A Clinical Study to Evaluate the Effect of Guduchighan Vati in the Management of Vatarakta w.s.r to Hyperuricemia

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/06/026079
Enrollment
30
Registered
2020-06-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E790- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease

Interventions

Intervention1: Guduchighan Vati: Guduchighan Vati 500mg 1BD for 6 weeks with water Control Intervention1: Tab Allopurinol: Tab Allopurinol 100mg 1BD for 6 weeks with water

Sponsors

College Principal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient of either sex in the age group between 20-70 years. 2.Patient having serum uric acid level more then 7mg/dl(male) and 6mg/dl(female) with or without any associated features of joint inflammation. 3.Willing to participate and able to provide signed informed consent.

Exclusion criteria

Exclusion criteria: 1.Patient not willing for the trial. 2.Patient below age of 20 years and above 70 years of age. 3.Patient suffering from any other form of Arthritis like R.A, O.A, Tubercular Arthritis, Rheumatoid Arthritis etc. 4.Patient suffering from chronic renal, respiratory, cardiac and hepatic disorders. 5.Patient having malignant disorders. 6. Patient who has completed participation in any other clinical trial during the past 3 months. 7.Any condition which the investigator thinks may compromise with the safety of the object.

Design outcomes

Primary

MeasureTime frame
Fulfillment of subjective and objective criteriaTimepoint: 6 Weeks

Secondary

MeasureTime frame
General feeling of well beingTimepoint: 6 weeks

Countries

India

Contacts

Public ContactDr Pooja Devi

RGGPG Ayurvedic College And Hospital Paprola

drvijaychaudhary@gmail.com9418130228

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026